Niagen Bioscience Statistics
Total Valuation
NAGE has a market cap or net worth of $581.02 million. The enterprise value is $523.99 million.
| Market Cap | 581.02M |
| Enterprise Value | 523.99M |
Important Dates
The next confirmed earnings date is Tuesday, November 4, 2025, after market close.
| Earnings Date | Nov 4, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
NAGE has 79.92 million shares outstanding. The number of shares has increased by 10.14% in one year.
| Current Share Class | 79.92M |
| Shares Outstanding | 79.92M |
| Shares Change (YoY) | +10.14% |
| Shares Change (QoQ) | +3.62% |
| Owned by Insiders (%) | 29.45% |
| Owned by Institutions (%) | 37.04% |
| Float | 52.57M |
Valuation Ratios
The trailing PE ratio is 33.78 and the forward PE ratio is 43.61.
| PE Ratio | 33.78 |
| Forward PE | 43.61 |
| PS Ratio | 4.84 |
| Forward PS | 4.11 |
| PB Ratio | 9.03 |
| P/TBV Ratio | 9.09 |
| P/FCF Ratio | 27.75 |
| P/OCF Ratio | 27.39 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 30.02, with an EV/FCF ratio of 25.03.
| EV / Earnings | 29.56 |
| EV / Sales | 4.51 |
| EV / EBITDA | 30.02 |
| EV / EBIT | 31.43 |
| EV / FCF | 25.03 |
Financial Position
The company has a current ratio of 3.88, with a Debt / Equity ratio of 0.05.
| Current Ratio | 3.88 |
| Quick Ratio | 3.16 |
| Debt / Equity | 0.05 |
| Debt / EBITDA | 0.18 |
| Debt / FCF | 0.16 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 37.36% and return on invested capital (ROIC) is 20.56%.
| Return on Equity (ROE) | 37.36% |
| Return on Assets (ROA) | 14.32% |
| Return on Invested Capital (ROIC) | 20.56% |
| Return on Capital Employed (ROCE) | 24.09% |
| Revenue Per Employee | $1.12M |
| Profits Per Employee | $170,471 |
| Employee Count | 104 |
| Asset Turnover | 1.60 |
| Inventory Turnover | 3.26 |
Taxes
In the past 12 months, NAGE has paid $601,000 in taxes.
| Income Tax | 601,000 |
| Effective Tax Rate | 3.28% |
Stock Price Statistics
The stock price has increased by +109.51% in the last 52 weeks. The beta is 2.13, so NAGE's price volatility has been higher than the market average.
| Beta (5Y) | 2.13 |
| 52-Week Price Change | +109.51% |
| 50-Day Moving Average | 8.80 |
| 200-Day Moving Average | 8.76 |
| Relative Strength Index (RSI) | 36.14 |
| Average Volume (20 Days) | 1,265,243 |
Short Selling Information
The latest short interest is 4.17 million, so 5.22% of the outstanding shares have been sold short.
| Short Interest | 4.17M |
| Short Previous Month | 3.75M |
| Short % of Shares Out | 5.22% |
| Short % of Float | 7.94% |
| Short Ratio (days to cover) | 3.92 |
Income Statement
In the last 12 months, NAGE had revenue of $116.30 million and earned $17.73 million in profits. Earnings per share was $0.22.
| Revenue | 116.30M |
| Gross Profit | 73.99M |
| Operating Income | 16.67M |
| Pretax Income | 18.33M |
| Net Income | 17.73M |
| EBITDA | 17.45M |
| EBIT | 16.67M |
| Earnings Per Share (EPS) | $0.22 |
Balance Sheet
The company has $60.32 million in cash and $3.29 million in debt, giving a net cash position of $57.03 million or $0.71 per share.
| Cash & Cash Equivalents | 60.32M |
| Total Debt | 3.29M |
| Net Cash | 57.03M |
| Net Cash Per Share | $0.71 |
| Equity (Book Value) | 64.20M |
| Book Value Per Share | 0.80 |
| Working Capital | 64.35M |
Cash Flow
In the last 12 months, operating cash flow was $21.21 million and capital expenditures -$277,000, giving a free cash flow of $20.93 million.
| Operating Cash Flow | 21.21M |
| Capital Expenditures | -277,000 |
| Free Cash Flow | 20.93M |
| FCF Per Share | $0.26 |
Margins
Gross margin is 63.62%, with operating and profit margins of 14.33% and 15.24%.
| Gross Margin | 63.62% |
| Operating Margin | 14.33% |
| Pretax Margin | 15.76% |
| Profit Margin | 15.24% |
| EBITDA Margin | 15.01% |
| EBIT Margin | 14.33% |
| FCF Margin | 18.00% |
Dividends & Yields
NAGE does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -10.14% |
| Shareholder Yield | -10.14% |
| Earnings Yield | 3.05% |
| FCF Yield | 3.60% |
Analyst Forecast
The average price target for NAGE is $17.00, which is 133.84% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $17.00 |
| Price Target Difference | 133.84% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on April 13, 2016. It was a reverse split with a ratio of 1:3.
| Last Split Date | Apr 13, 2016 |
| Split Type | Reverse |
| Split Ratio | 1:3 |
Scores
NAGE has an Altman Z-Score of 10.55 and a Piotroski F-Score of 7.
| Altman Z-Score | 10.55 |
| Piotroski F-Score | 7 |